At the same time, the application of intensive lipid-lowering therapy28, β-receptor blockers, angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor antagonists (ARBs) also significantly reduced the incidence of angina and recurring myocardial infarction after STEMI29. The gene discussed is ACE; the disease is angina pectoris.